BK

Balasubramaniyam Kalaikovan

Active Director Director DIN 11514425
DIN 11514425 First appointment Jan 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Total affiliations 2 Since Jan 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Balasubramaniyam Kalaikovan

Data last updated:

Balasubramaniyam Kalaikovan is a Director at Zukon Pharmaacare Private Limited (since 2026) and Director at Dr Sleep Qure Private Limited (since 2026).

DIN 11514425
Primary Designation Director
First Appointment 30 Jan 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Zukon Pharmaacare Private Limited U21001TN2026PTC189529
Director11 Feb 20262026Active
Dr Sleep Qure Private Limited U86100TN2026PTC189021
Director30 Jan 20262026Active

Board colleagues of Balasubramaniyam Kalaikovan

Directorship timeline

Open interactive timeline →
Zukon Pharmaacare Private Limited
Dr Sleep Qure Private Limited
Premium access

Shareholding and investment profile for Balasubramaniyam Kalaikovan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Balasubramaniyam Kalaikovan

Balasubramaniyam Kalaikovan currently holds 2 directorships: Zukon Pharmaacare Private Limited (Director, since 11 Feb 2026); Dr Sleep Qure Private Limited (Director, since 30 Jan 2026).

Balasubramaniyam Kalaikovan was first appointed on 30 Jan 2026 as Director at Dr Sleep Qure Private Limited.

The current boards of Balasubramaniyam Kalaikovan's companies include Kathirvel (Zukon Pharmaacare Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available